Gal‐3 regulates the capacity of dendritic cells to promote NKT‐cell‐induced liver injury

Galectin‐3 (Gal‐3), an endogenous lectin, exhibits pro‐ and anti‐inflammatory effects in various disease conditions. In order to explore the role of Gal‐3 in NKT‐cell‐dependent pathology, we induced hepatitis in C57BL/6 WT and Gal‐3‐deficient mice by using specific ligand for NKT cells: α‐galactosylceramide, glycolipid Ag presented by CD1d. The injection of α‐galactosylceramide significantly enhanced expression of Gal‐3 in liver NKT and dendritic cells (DCs). Genetic deletion or selective inhibition of Gal‐3 (induced by Gal‐3‐inhibitor TD139) abrogated the susceptibility to NKT‐cell‐dependent hepatitis. Blood levels of pro‐inflammatory cytokines (TNF‐α, IFN‐γ, IL‐12) and their production by liver DCs and NKT cells were also downregulated. Genetic deletion or selective inhibition of Gal‐3 alleviated influx of inflammatory CD11c+CD11b+ DCs in the liver and favored tolerogenic phenotype and IL‐10 production of liver NKT and DCs. Deletion of Gal‐3 attenuated the capacity of DCs to support liver damage in the passive transfer experiments and to produce pro‐inflammatory cytokines in vitro. Gal‐3‐deficient DCs failed to optimally stimulate production of pro‐inflammatory cytokines in NKT cells, in vitro and in vivo. In conclusion, Gal‐3 regulates the capacity of DCs to support NKT‐cell‐mediated liver injury, playing an important pro‐inflammatory role in acute liver injury.

[1]  A. Ohta,et al.  Extracellular adenosine controls NKT‐cell‐dependent hepatitis induction , 2014, European journal of immunology.

[2]  G. Rabinovich,et al.  Galectin‐3 negatively regulates the frequency and function of CD4+CD25+Foxp3+ regulatory T cells and influences the course of Leishmania major infection , 2013, European journal of immunology.

[3]  A. Fattorossi,et al.  Interleukin‐21 (IL‐21) synergizes with IL‐2 to enhance T‐cell receptor‐induced human T‐cell proliferation and counteracts IL‐2/transforming growth factor‐β‐induced regulatory T‐cell development , 2013, Immunology.

[4]  Claire N. Medine,et al.  Galectin-3 regulates hepatic progenitor cell expansion during liver injury , 2014, Gut.

[5]  H. Tajiri,et al.  Activated natural killer T cells producing interferon‐gamma elicit promoting activity to murine dendritic cell‐based autoimmune hepatic inflammation , 2012, Clinical and experimental immunology.

[6]  L. Nagy.  Would eating carrots protect your liver? A new role involving NKT cells for retinoic acid in hepatitis , 2012, European journal of immunology.

[7]  N. Arsenijević,et al.  Galectin‐3 deficiency prevents concanavalin A–induced hepatitis in mice , 2012, Hepatology.

[8]  N. Arsenijević,et al.  The roles of Galectin-3 in autoimmunity and tumor progression , 2012, Immunologic research.

[9]  S. Menini,et al.  Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. , 2011, Journal of hepatology.

[10]  H. Yoon,et al.  Galectin-3 Exerts Cytokine-Like Regulatory Actions through the JAK–STAT Pathway , 2010, The Journal of Immunology.

[11]  N. Hayashi,et al.  Activated liver dendritic cells generate strong acquired immunity in alpha-galactosylceramide treatment. , 2009, Journal of hepatology.

[12]  D. Hsu,et al.  Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. , 2009, The Journal of investigative dermatology.

[13]  M. Gershwin,et al.  CD4+CD25+ Foxp3+ Regulatory T Cells Protect against T Cell-Mediated Fulminant Hepatitis in a TGF-β-Dependent Manner in Mice1 , 2008, The Journal of Immunology.

[14]  G. Tiegs,et al.  α-Galactosylceramide-Induced Liver Injury in Mice Is Mediated by TNF-α but Independent of Kupffer Cells1 , 2005, The Journal of Immunology.

[15]  Toshihiro Ito,et al.  Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. , 2004, International immunology.

[16]  F. Leithäuser,et al.  Activating Immunity in the Liver. I. Liver Dendritic Cells (but Not Hepatocytes) Are Potent Activators of IFN-γ Release by Liver NKT Cells1 , 2001, The Journal of Immunology.

[17]  K. Matsushima,et al.  Regulation by Chemokines of Circulating Dendritic Cell Precursors, and the Formation of Portal Tract–Associated Lymphoid Tissue, in a Granulomatous Liver Disease , 2001, The Journal of experimental medicine.

[18]  L. Kaer,et al.  Activation of hepatic NKT cells and subsequent liver injury following administration of α‐galactosylceramide , 2000, European journal of immunology.

[19]  W. Fung-Leung,et al.  Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. , 2000, The American journal of pathology.

[20]  A. Wendel,et al.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.

[21]  N. Arsenijević,et al.  Protective role of IL-33/ST2 axis in Con A-induced hepatitis. , 2012, Journal of hepatology.

[22]  V. Rozados,et al.  Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model. , 2012, Experimental oncology.

[23]  D. Schmitt,et al.  TGFβ Inhibits CD1d Expression on Dendritic Cells , 2005 .

[24]  D. Schmitt,et al.  TGFbeta inhibits CD1d expression on dendritic cells. , 2005, The Journal of investigative dermatology.

[25]  G. Tiegs,et al.  Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. , 2005, Journal of immunology.